| Megan Crowe, PHARMD | |
|
720 Medical Center Dr, Newton, KS 67114-8778 | |
| (316) 284-5151 | |
| (316) 284-5161 |
| Full Name | Megan Crowe |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 720 Medical Center Dr, Newton, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306450531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-109496 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Crowe, PHARMD 720 Medical Center Dr, Newton, KS 67114-8778 Ph: (316) 284-5151 | Megan Crowe, PHARMD 720 Medical Center Dr, Newton, KS 67114-8778 Ph: (316) 284-5151 |
News Archive
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Pfizer Oncology will present data on a number of investigational compounds from its hematology portfolio, including new data from bosutinib in chronic myeloid leukemia (CML), inotuzumab in non-Hodgkin lymphoma (NHL), as well as the first presentation of clinical data for PF-04449913, which inhibits Smoothened (SMO), a key component of the Hedgehog pathway.
Antigenics, Inc. today announced the expansion of a phase 2 clinical study of HSPPC-96 (Oncophage® vaccine; vitespen), Antigenics' personalized therapeutic cancer vaccine, in patients with newly diagnosed glioma.
Interestingly, a recent study found that ischemic stress causes hyperglycemia and may worsen ischemic neuronal damage. In addition, decreased insulin sensitivity after ischemic stress seems to be involved in the development of post-ischemic glucose intolerance.
The long-awaited results from the first large international trial to try to prevent type 1 diabetes shows that modified baby formula in which cow's milk proteins have been split does not prevent type 1 diabetes in children with genetic risk factors for the condition, according to researchers at Children's Hospital of Pittsburgh of UPMC, the coordinating center for the U.S. arm of the study.
› Verified 9 days ago
Daniel Lindenmeyer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1410 S Kansas Ave, Newton, KS 67114 Phone: 316-284-3725 Fax: 316-284-3728 | |
Walter Barrett Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 N Main St, Newton, KS 67114 Phone: 316-281-9356 | |
Brian Steventon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1216 N Main St, Newton, KS 67114 Phone: 316-283-6770 | |
Heath Allen Kerr, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1216 N Main St, Newton, KS 67114 Phone: 316-283-6770 Fax: 316-284-3719 | |
Miss Diana Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 N Main St, Newton, KS 67114 Phone: 316-281-9356 | |
Mrs. Christen Martens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1216 N Main St, Newton, KS 67114 Phone: 316-283-6771 Fax: 316-284-3719 | |
Tina Reese, PHARMICIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 |